Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-25 @ 3:47 AM
NCT ID:
NCT01152502
Brief Summary:
Follow-up of urinary concentration from paracetamol metabolites by patients with aortic surgery during 4 days therapeutic intake (perfalgan ® 4 x 1g IV/day)
Detailed Description:
D-15 to D0: selection
* patient information and non-opposition obtained
* inclusion and non inclusion criteria check
* clinical exam
D-1 to D0 : 24 hours diuresis
D0 : operation day
Before anesthesia :
* urine collection (paracetamol metabolites dosage)
* blood sampling (glutathion and liver function test)
Surgery:
* 1st paracetamol intake before closing
* Then administration every 6 hours
D1 to D4 :
* 24 hours urine collection (metabolites dosage)
* blood sampling et D1 and D4(glutathion and liver function test)
D5 : final clinical exam
Study:
NCT01152502
Study Brief:
Protocol Section:
NCT01152502